Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1983 Mar;36(3):357–360. doi: 10.1136/jcp.36.3.357

Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

M P Jarrett, D Green, C H Ts'ao
PMCID: PMC498214  PMID: 6826782

Abstract

The increased frequency of thromboembolic events in patients with systemic lupus erythematosus (SLE) has been attributed to reduced or dysfunctional antithrombin III (At-III). We analysed At-III values, measured by three different assay techniques, in SLE patients, patients with rheumatoid arthritis, and normal and hospitalised controls. In addition, attempts were made to correlate At-III activities of SLE patients with specific clinical and serological parameters such as disease activity, renal involvement, previous thrombosis, degree of proteinuria, and serum complement concentrations. Our results failed to show a significantly reduced At-III in SLE with any method. At-III titres did not correlate with disease activity, concentrations of serum complement or albumin (both only minimally reduced in most patients), or a previous history of thrombosis. At-III deficiency does not appear to be an inherent feature of SLE, and reduced activities should only be anticipated when there are specific aetiological factors present, such as massive proteinuria, extensive hepatic disease, or active thrombosis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angles-Cano E., Sultan Y., Clauvel J. P. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage. J Lab Clin Med. 1979 Aug;94(2):312–323. [PubMed] [Google Scholar]
  2. BOWIE E. J., THOMPSON J. H., Jr, PASCUZZI C. A., OWEN C. A., Jr THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. J Lab Clin Med. 1963 Sep;62:416–430. [PubMed] [Google Scholar]
  3. Bick R. L., Kovacs I., Fekete L. F. A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation. Thromb Res. 1976 Jun;8(6):745–756. doi: 10.1016/0049-3848(76)90003-7. [DOI] [PubMed] [Google Scholar]
  4. Braunstein K. M., Eurenius K. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis. Am J Clin Pathol. 1976 Sep;66(3):488–494. doi: 10.1093/ajcp/66.3.488. [DOI] [PubMed] [Google Scholar]
  5. Carvalho A., Ellman L. Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function. Am J Med. 1976 Aug;61(2):179–183. doi: 10.1016/0002-9343(76)90167-4. [DOI] [PubMed] [Google Scholar]
  6. Cosgriff T. M., Martin B. A. Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum. 1981 Jan;24(1):94–96. doi: 10.1002/art.1780240115. [DOI] [PubMed] [Google Scholar]
  7. EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
  8. Gladman D. D., Urowitz M. B. Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis. 1980 Aug;39(4):340–343. doi: 10.1136/ard.39.4.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Innerfield I., Goldfischer J. D., Reicher-Reiss H., Greenberg J. Serum antithrombin in coronary-artery disease. Am J Clin Pathol. 1976 Jan;65(1):64–68. doi: 10.1093/ajcp/65.1.64. [DOI] [PubMed] [Google Scholar]
  10. Jarrett M. P., Grayzel A. I., Barland P., Sussman I. Acquired antithrombin III deficiency and systemic lupus erythematosus. Ann Rheum Dis. 1981 Apr;40(2):211–211. doi: 10.1136/ard.40.2.211-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kauffmann R. H., Veltkamp J. J., Van Tilburg N. H., Van Es L. A. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med. 1978 Oct;65(4):607–613. doi: 10.1016/0002-9343(78)90848-3. [DOI] [PubMed] [Google Scholar]
  12. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  13. Mackie M., Bennett B., Ogston D., Douglas A. S. Familial thrombosis: inherited deficiency of antithrombin III. Br Med J. 1978 Jan 21;1(6106):136–138. doi: 10.1136/bmj.1.6106.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marciniak E., Farley C. H., DeSimone P. A. Familial thrombosis due to antithrombin 3 deficiency. Blood. 1974 Feb;43(2):219–231. [PubMed] [Google Scholar]
  15. Mitchell G. A., Hudson P. M., Huseby R. M., Pochron S. P., Gargiulo R. J. Fluorescent substrate assay for antithrombin III. Thromb Res. 1978 Feb;12(2):219–225. doi: 10.1016/0049-3848(78)90293-1. [DOI] [PubMed] [Google Scholar]
  16. Mueh J. R., Herbst K. D., Rapaport S. I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med. 1980 Feb;92(2 Pt 1):156–159. doi: 10.7326/0003-4819-92-2-156. [DOI] [PubMed] [Google Scholar]
  17. Sas G., Blaskó G., Bánhegyi D., Jákó J., Pálos L. A. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Thromb Diath Haemorrh. 1974 Sep 30;32(1):105–115. [PubMed] [Google Scholar]
  18. Scully M. F., De Haas H., Chan P., Kakkar V. V. Hereditary antithrombin III deficiency in an English family. Br J Haematol. 1981 Feb;47(2):235–240. doi: 10.1111/j.1365-2141.1981.tb02784.x. [DOI] [PubMed] [Google Scholar]
  19. Sørensen P. J., Sas G., Petó I., Blaskó G., Kremmer T., Samu A. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'. Thromb Res. 1982 May 1;26(3):211–219. doi: 10.1016/0049-3848(82)90142-6. [DOI] [PubMed] [Google Scholar]
  20. Thaler E., Balzar E., Kopsa H., Pinggera W. F. Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis. 1978;7(5):257–272. doi: 10.1159/000214268. [DOI] [PubMed] [Google Scholar]
  21. Yue R. H., Gertler M. M., Starr T., Koutrouby R. Alteration of plasma antithrombin III levels in ischemic heart disease. Thromb Haemost. 1976 Jun 30;35(3):598–606. [PubMed] [Google Scholar]
  22. van der Meer J., Stoepman-van Dalen E. A., Jansen J. M. Antithrombin-3 deficiency in a Dutch family. J Clin Pathol. 1973 Jul;26(7):532–538. doi: 10.1136/jcp.26.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES